Ascentage Pharma Group International (AAPG) Stock Chart & Stock Price History $34.61 -1.84 (-5.05%) As of 02:59 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Ascentage Pharma Group International Stock Price Performance The Ascentage Pharma Group International (AAPG) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has decreased 14.46%, reflecting recent market activity. As of the latest close, Ascentage Pharma Group International traded at $36.45 with a market cap of $3.40 billion and volume of 7,139 shares. Receive AAPG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ascentage Pharma Group International and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-6.48%1 Month Performance-14.46%3 Month Performance-4.39% AAPG Stock Chart for Tuesday, October, 14, 2025 AAPG Chart by TradingView Ascentage Pharma Group International Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/13/2025$34.94$36.45+4.32%$36.45$35.897,139 shs$3.40 billion10/10/2025$37.01$34.94-5.59%$36.80$34.9411,572 shs$3.26 billion10/09/2025$40.23$37.01-8.00%$38.58$37.005,365 shs$3.45 billion10/08/2025$38.88$40.23+3.47%$40.23$39.446,795 shs$3.75 billion10/07/2025$39.86$38.88-2.46%$39.15$38.885,664 shs$3.62 billion10/06/2025$39.38$39.86+1.22%$39.86$39.402,583 shs$3.71 billion10/03/2025$39.78$39.38-1.01%$39.90$38.855,681 shs$3.67 billion10/02/2025$39.58$39.78+0.51%$40.47$38.909,581 shs$3.71 billion10/01/2025$39.04$39.58+1.38%$39.94$39.002,402 shs$3.64 billion09/30/2025$38.55$39.04+1.27%$39.79$39.042,775 shs$3.64 billion Get the Latest News and Ratings for AAPG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ascentage Pharma Group International and its competitors with MarketBeat's FREE daily newsletter. 09/29/2025$37.33$38.55+3.27%$39.70$38.3813,455 shs$3.59 billion09/26/2025$37.83$37.33-1.32%$37.33$37.202,481 shs$3.48 billion09/25/2025$37.41$37.83+1.12%$38.17$37.4410,461 shs$3.52 billion09/24/2025$38.08$37.41-1.76%$37.53$37.152,026 shs$3.49 billion09/23/2025$38.31$38.08-0.60%$38.33$38.005,617 shs$3.55 billion09/22/2025$38.85$38.31-1.39%$38.93$38.0019,183 shs$3.57 billion09/19/2025$39.35$38.85-1.27%$38.96$37.9921,030 shs$3.62 billion09/18/2025$38.95$39.35+1.03%$39.52$39.272,867 shs$3.67 billion09/17/2025$39.21$38.95-0.66%$39.05$38.505,936 shs$3.63 billion09/16/2025$38.63$39.21+1.50%$39.21$38.635,983 shs$3.65 billion09/15/2025$40.46$38.63-4.52%$39.98$38.6310,974 shs$3.60 billion Related Companies ASND Stock Price Chart RDY Stock Price Chart VTRS Stock Price Chart ROIV Stock Price Chart BBIO Stock Price Chart MRNA Stock Price Chart QGEN Stock Price Chart ELAN Stock Price Chart VRNA Stock Price Chart RVMD Stock Price Chart Receive AAPG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ascentage Pharma Group International and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AAPG) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredWhy Wall Street is piling into the “Debasement Trade”Wall Street is piling into what insiders are calling the “Debasement Trade” — and according to former Goldman ...Stansberry Research | SponsoredBuy alert: Move $1,000 before Tesla’s Optimus launchElon's $1,000,000,000,000 payday Elon Musk just made his biggest insider purchase of Tesla stock ever. He's...Altimetry | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ascentage Pharma Group International - Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Ascentage Pharma Group International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
